Risk factors for pulmonary infection after diagnostic bronchoscopy in patients with lung cancer.


Journal

Nagoya journal of medical science
ISSN: 2186-3326
Titre abrégé: Nagoya J Med Sci
Pays: Japan
ID NLM: 0412011

Informations de publication

Date de publication:
Feb 2020
Historique:
entrez: 11 4 2020
pubmed: 11 4 2020
medline: 29 1 2021
Statut: ppublish

Résumé

Pulmonary infection is a relatively rare but serious complication of flexible bronchoscopy. The aim of this study was to identify the risk factors for pulmonary infectious complications after diagnostic bronchoscopy in patients with lung cancer. We retrospectively analyzed the medical records of 636 patients who underwent bronchoscopic biopsy for lung cancer diagnosis between April 2011 and March 2016. We compared patients' characteristics, chest computed tomography and bronchoscopic findings, undertaken procedures, and final diagnoses between patients who developed the complication and those who did not. Pulmonary infection after the diagnostic bronchoscopy occurred in 19 patients (3.0%) and included pneumonia in 16 patients and lung abscess in 3. Patients with larger lesions, presence of endobronchial lesions, histology of small cell lung cancer, and advanced disease stage tended to develop pulmonary infectious complications more often. Our multivariate analysis revealed that a larger lesion size and the presence of endobronchial lesions were independently associated with post-bronchoscopy pulmonary infection. Although we found no mortality associated with the infections, two patients were left with significant performance status deterioration after the pulmonary infection and received no anticancer treatment. In conclusion, endobronchial lesions and a larger lesion size are independent risk factors for the incidence of infections following bronchoscopic biopsy in patients with lung cancer.

Identifiants

pubmed: 32273634
doi: 10.18999/nagjms.82.1.69
pmc: PMC7103861
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-77

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest.

Références

Eur Clin Respir J. 2016 Nov 11;3:33324
pubmed: 27839531
Am J Respir Crit Care Med. 2014 Mar 15;189(6):640-9
pubmed: 24484269
Respir Investig. 2017 May;55(3):212-218
pubmed: 28427748
Respirology. 2017 Apr;22(3):521-526
pubmed: 27860040
Intern Med. 2016;55(13):1705-12
pubmed: 27374669
J Am Geriatr Soc. 2006 May;54(5):827-30
pubmed: 16696751
Respiration. 2008;76(4):429-33
pubmed: 18716395
Chest. 2013 May;143(5 Suppl):e142S-e165S
pubmed: 23649436
Thorax. 2013 Aug;68 Suppl 1:i1-i44
pubmed: 23860341
Br Med J (Clin Res Ed). 1987 May 9;294(6581):1199
pubmed: 3109580
Respirology. 2007 Jan;12(1):70-5
pubmed: 17207028
Chest. 1999 May;115(5):1237-41
pubmed: 10334133
Geriatr Gerontol Int. 2013 Oct;13(4):986-92
pubmed: 23461485
Respirology. 2012 Apr;17(3):478-85
pubmed: 22222022
Int J Tuberc Lung Dis. 2011 Apr;15(4):528-35
pubmed: 21396214
Kobe J Med Sci. 2012 Dec 13;58(4):E110-8
pubmed: 23660451

Auteurs

Takahiro Shimizu (T)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Respiratory Medicine, Ichinomiya Municipal Hospital, Ichinomiya, Japan.

Shotaro Okachi (S)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Naoyuki Imai (N)

Respiratory Medicine, Gifu Prefectural Tajimi Hospital, Gifu, Japan.

Tetsunari Hase (T)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masahiro Morise (M)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Naozumi Hashimoto (N)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Mitsuo Sato (M)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Radiological and Medical Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yoshinori Hasegawa (Y)

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH